The Other Stem Cell Debate
By Jamie Shreeve,
The New York Times
| 04. 10. 2005
Except for the three million human brain cells injected into his
cranium, XO47 is just an average green vervet monkey. He weighs about
12 pounds and measures 34 inches from the tip of his tail to the
sutured incision on the top of his head. His fur is a melange of black,
yellow and olive, with white underparts and a coal-black face. Until
his operation, two days before I met him, he was skittering about an
open-air enclosure on the grounds of a biomedical facility on the
Caribbean island of St. Kitts. Afterward, he was caged in a hut shared
with half a dozen other experimental monkeys, all of whom bore
identical incisions in their scalps. Judging from the results of
previous experiments, the human neural stem cells inserted into their
brains would soon take hold and begin to grow, their fibers reaching
out to shake hands with their monkey counterparts. The green vervets'
behavior was, and will remain, all monkey. To a vervet, eye contact
signals aggression, and when I peered into X047's cage, he took
umbrage, vigorously bobbing...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...